2027 Co-op Cell Medicines Research & Development
Regeneron Pharmaceuticals
Summary
Regeneron is currently seeking multiple 2027 Co-ops to join our Regeneron Cell Medicines (RCM) team, Regeneron's cell therapy unit developing next-generation T-cell therapies for cancer.
Job description
When & where
Location: Cambridge, MA / Seattle, WA. Our Co-op positions are full-time and onsite from January-August (Spring-Summer), May/June-December (Summer-Fall), and August-December (Fall).
What you'll do
- Support in vitro safety and efficacy testing of cell therapy candidates
- Develop tumor antigen expression and flow cytometry methods
- Contribute to viral-vector production and process development for cell engineering
- Support high-throughput protein production activities
- Contribute to analytical method development supporting Good Manufacturing Practice (GMP) manufacturing
- Support digital-transformation initiatives for manufacturing operations
- Document experimental procedures and results
- Collaborate with scientists across the cell therapy team
Relevant majors
Biology, Biochemistry, Biomedical Engineering
Let's find out if we're a fit
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Requirements
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Relevant majors: Biology, Biochemistry, Biomedical Engineering
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.